サンバイオの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/03 | 3,580 | 3,585 | 3,435 | 3,455 | -110 | -3.1% | 421,000 |
2019/07/02 | 3,525 | 3,580 | 3,500 | 3,565 | +45 | +1.3% | 391,700 |
2019/07/01 | 3,485 | 3,535 | 3,470 | 3,520 | +60 | +1.7% | 392,400 |
2019/06/28 | 3,395 | 3,485 | 3,395 | 3,460 | +70 | +2.1% | 414,800 |
2019/06/27 | 3,350 | 3,400 | 3,325 | 3,390 | +15 | +0.4% | 259,400 |
2019/06/26 | 3,270 | 3,405 | 3,265 | 3,375 | +55 | +1.7% | 426,600 |
2019/06/25 | 3,385 | 3,410 | 3,280 | 3,320 | -115 | -3.3% | 557,500 |
2019/06/24 | 3,280 | 3,440 | 3,180 | 3,435 | +135 | +4.1% | 1,090,700 |
2019/06/21 | 3,505 | 3,520 | 3,275 | 3,300 | -230 | -6.5% | 1,180,000 |
2019/06/20 | 3,575 | 3,590 | 3,480 | 3,530 | -50 | -1.4% | 747,900 |
2019/06/19 | 3,675 | 3,675 | 3,560 | 3,580 | -45 | -1.2% | 527,900 |
2019/06/18 | 3,730 | 3,785 | 3,620 | 3,625 | -110 | -2.9% | 670,700 |
2019/06/17 | 3,740 | 3,785 | 3,715 | 3,735 | -75 | -2% | 530,000 |
2019/06/14 | 3,740 | 3,825 | 3,705 | 3,810 | +115 | +3.1% | 581,600 |
2019/06/13 | 3,755 | 3,755 | 3,650 | 3,695 | -85 | -2.2% | 487,200 |
2019/06/12 | 3,815 | 3,830 | 3,760 | 3,780 | -55 | -1.4% | 329,400 |
2019/06/11 | 3,835 | 3,855 | 3,810 | 3,835 | -10 | -0.3% | 261,600 |
2019/06/10 | 3,855 | 3,880 | 3,800 | 3,845 | +55 | +1.5% | 386,800 |
2019/06/07 | 3,830 | 3,840 | 3,725 | 3,790 | +20 | +0.5% | 429,600 |
2019/06/06 | 3,845 | 3,910 | 3,770 | 3,770 | -70 | -1.8% | 630,900 |
2019/06/05 | 3,830 | 3,890 | 3,800 | 3,840 | +80 | +2.1% | 502,300 |
2019/06/04 | 3,595 | 3,760 | 3,595 | 3,760 | +165 | +4.6% | 794,800 |
2019/06/03 | 3,770 | 3,795 | 3,540 | 3,595 | -230 | -6% | 934,700 |
2019/05/31 | 3,820 | 3,855 | 3,775 | 3,825 | +25 | +0.7% | 443,500 |
2019/05/30 | 3,805 | 3,830 | 3,745 | 3,800 | -55 | -1.4% | 604,800 |
2019/05/29 | 3,920 | 3,985 | 3,850 | 3,855 | -100 | -2.5% | 803,000 |
2019/05/28 | 3,905 | 3,975 | 3,885 | 3,955 | +70 | +1.8% | 877,800 |
2019/05/27 | 3,815 | 3,960 | 3,770 | 3,885 | +75 | +2% | 1,098,700 |
2019/05/24 | 3,705 | 3,810 | 3,680 | 3,810 | +80 | +2.1% | 537,800 |
2019/05/23 | 3,800 | 3,820 | 3,705 | 3,730 | -35 | -0.9% | 506,700 |
2019/05/22 | 3,745 | 3,830 | 3,715 | 3,765 | +80 | +2.2% | 917,400 |
2019/05/21 | 3,720 | 3,745 | 3,540 | 3,685 | -45 | -1.2% | 1,355,400 |
2019/05/20 | 3,800 | 3,870 | 3,720 | 3,730 | -70 | -1.8% | 663,000 |
2019/05/17 | 3,925 | 3,935 | 3,780 | 3,800 | -70 | -1.8% | 819,000 |
2019/05/16 | 3,850 | 3,950 | 3,825 | 3,870 | +25 | +0.7% | 1,054,400 |
2019/05/15 | 3,770 | 3,885 | 3,720 | 3,845 | -235 | -5.8% | 2,619,900 |
2019/05/14 | 4,050 | 4,195 | 4,035 | 4,080 | -130 | -3.1% | 1,273,500 |
2019/05/13 | 3,935 | 4,265 | 3,910 | 4,210 | +90 | +2.2% | 1,829,900 |
2019/05/10 | 4,295 | 4,400 | 4,075 | 4,120 | -280 | -6.4% | 1,653,200 |
2019/05/09 | 4,545 | 4,560 | 4,400 | 4,400 | -120 | -2.7% | 896,900 |
2019/05/08 | 4,520 | 4,615 | 4,480 | 4,520 | +35 | +0.8% | 1,666,500 |
2019/05/07 | 4,450 | 4,625 | 4,385 | 4,485 | -5 | -0.1% | 2,200,500 |
2019/04/26 | 4,400 | 4,550 | 4,370 | 4,490 | +70 | +1.6% | 3,890,200 |
2019/04/25 | 4,495 | 4,750 | 4,385 | 4,420 | +255 | +6.1% | 10,909,000 |
2019/04/24 | 4,300 | 4,350 | 4,160 | 4,165 | -25 | -0.6% | 2,306,500 |
2019/04/23 | 4,070 | 4,310 | 4,050 | 4,190 | +105 | +2.6% | 4,313,700 |
2019/04/22 | 4,110 | 4,320 | 4,060 | 4,085 | -305 | -6.9% | 4,339,000 |
2019/04/19 | 4,710 | 4,780 | 4,140 | 4,390 | -320 | -6.8% | 12,764,000 |
2019/04/18 | 4,500 | 4,710 | 4,360 | 4,710 | +700 | +17.5% | 9,718,400 |
2019/04/17 | 3,510 | 4,010 | 3,410 | 4,010 | +700 | +21.1% | 9,815,600 |
1501~
1550
件表示中 / 2536件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サンバイオ | 253,000円 | - | - | 0.00% | - | 117.18倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
ペプチド | 152,500円 | +5.0% | +1.5% | 0.00% | 13.05倍 | 3.67倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
科研薬 | 388,200円 | -6.4% | -71.8% | 4.89% | 43.23倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
東和薬品 | 304,000円 | +7.9% | -3.3% | 2.63% | 8.46倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム